Jazz Pharmaceuticals(JAZZ)
$236.45-11.32 (-4.57%)
JAZZ
Jazz Pharmaceuticals earnings date
$236.45
At close:-11.32 (-4.57%)
Want to see JAZZ full AI Analyst Report?
Jazz Pharmaceuticals (JAZZ) Q2 2024 Earnings Report
1,946 Followers
JAZZ Q2 2024 EPS Results
- Actual EPS
- $5.30
- Consensus EPS
- $4.92
- Beat/Miss
- Beat by +$0.38
- One Year Ago EPS
- $4.51
JAZZ Q2 2024 Revenue Results
- Actual Revenue
- $1.02B
- Expected Revenue
- $1.01B
- Beat/Miss
- Beat by +$13.86M
- YoY Revenue Growth
- +6.95%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/31/2024
- Time
- After Close
- Conference Call
- Wednesday, July 31, 2024
JAZZ Upcoming Earnings
Jazz Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
JAZZ Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
JAZZ Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 6.96- | 6.64 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -4.03-3.88 | 8.13 | -147.72% (-12.01) | |
| Aug 03, 2026 | 2026 (Q2) | 6.175.71 | -8.25 | 169.21% (+13.96) | |
| May 05, 2026 | 2026 (Q1) | 4.646.34 | 1.68 | 277.38% (+4.66) | |
| Feb 24, 2026 | 2025 (Q4) | 6.526.64 | 6.6 | 0.61% (+0.04) | |
| Nov 05, 2025 | 2025 (Q3) | 5.958.13 | 6.61 | 23.00% (+1.52) | |
| Aug 05, 2025 | 2025 (Q2) | -7.61-8.25 | 5.3 | -255.66% (-13.55) | |
| May 06, 2025 | 2025 (Q1) | 4.661.68 | 2.68 | -37.31% (-1.00) | |
| Feb 25, 2025 | 2024 (Q4) | 5.866.60 | 5.02 | 31.47% (+1.58) | |
| Nov 06, 2024 | 2024 (Q3) | 5.506.61 | 4.84 | 36.57% (+1.77) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


